Case Report Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia A Case Series
نویسندگان
چکیده
Université Denis Diderot–Paris 7, Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Saint-Louis, Paris, France; INSERM CIC 9504, Centre d’Investigations Cliniques, Paris, France; Université Denis Diderot–Paris 7, Assistance Publique-Hôpitaux de Paris, Service d’Hématologie, Hôpital Saint-Louis, Paris, France; Université Denis Diderot–Paris 7, Assistance Publique-Hôpitaux de Paris, Service de Pathologie, Hôpital Saint-Louis, Paris, France; and Université de Versailles Saint-Quentin en Yvelines, Service d’Hématologie Hôpital Mignot, Le Chesnay, France
منابع مشابه
Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.
Tyrosine kinase inhibitors have revolutionized the treatment of chronic myeloid leukemia and are increasingly used for other indications. Fluid retention, however, including pleural effusions, are a significant side effect of imatinib, the first-line treatment for chronic myeloid leukemia. We investigated pleural and pulmonary complications in patients treated with dasatinib, a novel multitarge...
متن کاملTherapy-related myeloid leukemia following Pleuropulmonary blastoma: A case report
The development of secondary malignancy (SM) is the most worrisome long-term complication of childhood cancer. Acute myeloid leukemia is the most prevalent neoplasm that occurs after treatment with alkylating agents and topoisomerase II inhibitors. Pleuropulmonary blastoma (PPB) is a rare lung neoplasm in children. Type II and type III of this cancer are markedly aggressive and have a recurrent...
متن کاملChronic myeloid leukemia following colon cancer treatment: A case report and literature review
Background: Solid tumors may occur in 3% of the patients with chronic myeloid leukemia (CML). In this paper, we presented a case of CML following treatment of colon cancer. Case Presentation: A 25 year old man was diagnosed of adenocarcinoma of rectosigmoid treated with fluorouracil-based chemotherapy. Following relapse, he received florouracil, oxaliplatin and irinotecan during the next year. ...
متن کاملDasatinib-induced chylothorax in chronic myeloid leukemia.
Pulmonary adverse events are common abnormalities associated with the use of dasatinib in chronic myeloid leukemia. We present a case of a 69-year-old man who suddenly developed a rare chylothorax pulmonary adverse event following 10 months of dasatinib treatment.
متن کاملSuccessful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester.
We report a case of a 25-year-old woman with chronic myeloid leukaemia who was randomised to dasatinib 100 mg orally daily in a clinical trial. The patient was advised to avoid pregnancy while on treatment due to its teratogenic potential. Five months later, the patient was found to be 6 weeks pregnant. Once pregnancy was confirmed, dasatinib was immediately stopped and the patient was taken of...
متن کامل